Literature DB >> 29369436

Sphingomyelin in microdomains of the plasma membrane regulates amino acid-stimulated mTOR signal activation.

Kota Zama1, Susumu Mitsutake2, Toshiro Okazaki3, Yasuyuki Igarashi1.   

Abstract

Sphingomyelin (SM) is required for cells to proliferate, but the reason is not fully understood. In order to asses this question, we employed a cell line, ZS, which lacks both SMS1 and SMS2, isolated from mouse embryonic fibroblasts in SMS1 and 2 double knockout mouse, and SMS1 or SMS2 re-expressing cells, ZS/SMS1 or ZS/SMS2, respectively. We investigated regulation of SM in activating the mammalian target of rapamycin (mTOR) signal induced by essential amino acids (EAA), using these cells. EAA-stimulated mTOR signal was more activated in ZS/SMS1 and ZS/SMS2 cells than in controls. Treatment with methyl-b-cyclodextrin dramatically inhibited the activation. Interestingly, we found that the expression of CD98, LAT-1 and ASCT-2, amino acid transporters concerned with mTOR activation, was down-regulated in ZS cells. Transporters localized in microdomains and formed a functional complex. Our results indicate that SM affect proliferation through the transport of amino acids via SM-enriched microdomains.
© 2018 International Federation for Cell Biology.

Entities:  

Keywords:  amino acid; lipid microdomains; mTOR; sphingomyelin; sphingomyelin synthase

Mesh:

Substances:

Year:  2018        PMID: 29369436     DOI: 10.1002/cbin.10941

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.

Authors:  Oana A Zeleznik; Clary B Clish; Peter Kraft; Julian Avila-Pacheco; A Heather Eliassen; Shelley S Tworoger
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

2.  Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer.

Authors:  Yan Deng; Jia-Chun Hu; Shu-Hua He; Bin Lou; Ting-Bo Ding; Jin-Tong Yang; Ming-Guang Mo; De-Yong Ye; Lu Zhou; Xian-Cheng Jiang; Ker Yu; Ji-Bin Dong
Journal:  Acta Pharmacol Sin       Date:  2020-05-25       Impact factor: 6.150

Review 3.  Ceramide Transfer Protein (CERT): An Overlooked Molecular Player in Cancer.

Authors:  Long Hoa Chung; Da Liu; Xin Tracy Liu; Yanfei Qi
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.